<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kritsi, E.</style></author><author><style face="normal" font="default" size="100%">Potamitis, C.</style></author><author><style face="normal" font="default" size="100%">Durdagi, S.</style></author><author><style face="normal" font="default" size="100%">Zoumpoulakis, P.</style></author><author><style face="normal" font="default" size="100%">Golic Grdadolnik, S.</style></author><author><style face="normal" font="default" size="100%">Mavromoustakos, T.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Molecular insights into the AT&lt;inf&gt;1&lt;/inf&gt; antagonism based on biophysical and in silico studies of telmisartan</style></title><secondary-title><style face="normal" font="default" size="100%">Medicinal Chemistry Research</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84883459426&amp;doi=10.1007%2fs00044-012-0464-5&amp;partnerID=40&amp;md5=a7081858927260d093b5d9f7a5f01b1c</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">22</style></volume><pages><style face="normal" font="default" size="100%">4842 - 4857</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><issue><style face="normal" font="default" size="100%">10</style></issue><notes><style face="normal" font="default" size="100%">Cited By :1Export Date: 23 August 2017</style></notes></record></records></xml>